Here are five things to know:
1. Under the new legislation, drugstores are not held to certain standards of credentialing, drug utilization evaluation activities and quality-of-care reviews.
2. These exemptions could result in increased prescription drug costs by $350 million in 2017, according to a new study released by the Pharmaceutical Care Management Association.
3. The study found this number could increase by $5.6 billion over the next 10 years.
4. Another piece of New York legislation, posing barriers for home delivery of traditional and specialty medicines, could negatively impact patient safety.
5. The study found the legislation would also weaken pharmacy network contracts.
More articles on quality & infection control:
Top 10 states with the highest & lowest ASC patient burn rates
FDA eases paperwork burden for experimental drugs — 5 notes
BCH researchers develop trigger tool to aid in adverse event tracking — 4 points
